IR-Med (IRME) Shares Outstanding (2020 - 2025)

IR-Med has disclosed Shares Outstanding across 6 years of filings, most recently posting $77.2 million for Q2 2025.

• Shares Outstanding for Q2 2025 came in at $77.2 million, up 9.25% year-over-year; the trailing twelve-month figure through Jun 2025 was $77.2 million (up 9.25% YoY), and the FY2024 annual result was $71.0 million, up 1.54% from the prior year.
• Shares Outstanding came in at $77.2 million for Q2 2025 at IR-Med, up from $72.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $77.2 million in Q2 2025 to a low of $64.0 million in Q1 2021.
• The 5-year median for Shares Outstanding is $69.3 million (2023), against an average of $68.8 million.
• Across the five-year window, Shares Outstanding surged 111.61% in 2021 and gained 0.98% in 2022, its largest moves.
• IR-Med's Shares Outstanding stood at $64.6 million in 2021, then advanced by 6.51% to $68.8 million in 2022, then grew by 1.63% to $69.9 million in 2023, then increased by 1.54% to $71.0 million in 2024, then gained by 8.77% to $77.2 million in 2025.
• The last three Shares Outstanding figures came in at $77.2 million (Q2 2025), $72.0 million (Q1 2025), and $71.0 million (Q4 2024), per Business Quant data.